Unitaid

UNICEF and Unitaid join forces to improve the health of children, adolescents and mothers

Geneva, 29 May 2019 –Unitaid and UNICEF will collaborate to save the lives of more children, adolescents and mothers, an agreement formalized by a memorandum of understanding signed today.

Read More →

Unitaid and Japan move to align their efforts against TB

Tokyo, 2 April 2019 — Unitaid Executive Director Lelio Marmora and Parliamentary Vice-Minister for Foreign Affairs of Japan Kenji Yamada met today to discuss a new alignment between Japan’s global health priorities and Unitaid’s work in fighting tuberculosis.

Read More →

CROI 2019: New study is a breakthrough for preventing TB in people living with HIV

Geneva – A Unitaid-funded study has found that 3HP, a new, shorter preventive therapy for tuberculosis, is safe for people who also take the HIV drug dolutegravir. The results mark a critical milestone for countries and funding partners seeking to expand preventive TB therapy.

Read More →

Unitaid seeks innovative, long-lasting technologies to help tackle diseases

Geneva – Unitaid is pleased to announce a call for proposals for projects speeding development of long-acting versions of medicines that could potentially revolutionize treatment and prevention of diseases including HIV, tuberculosis and malaria in low- and middle-income countries.

Read More →

Unitaid extends support to WHO prequalification programme

Geneva, 30 January 2019 – Unitaid is investing a further $22.1 million in the World Health Organization´s (WHO) prequalification programme for medicines and diagnostics.

Read More →

MPP and Unitaid publish intellectual property report on long-acting technologies

The Medicines Patent Pool (MPP) and Unitaid have jointly published a study into the patent landscape for long-acting technologies with the potential to have a major impact on preventing or treating HIV, hepatitis C, tuberculosis, and malaria in low- and middle-income countries.

Read More →

Unitaid extends key research grant as part of a strong counterattack on TB

New York, 25 September 2018 – Unitaid is intensifying its commitment to fighting tuberculosis with a US$ 21 million investment in extending endTB, a global research project that is improving treatment regimens for patients with multidrug-resistant tuberculosis (MDR-TB).

Read More →

Price cut on medicine will help preserve the health of more people living with HIV

Geneva, 08 June 2018 — Unitaid and Indian drug manufacturer Cipla Ltd. struck a landmark agreement today that will lower the price of the first combination therapy (containing co-trimoxazole, isoniazid and vitamin B6) that prevents opportunistic infections in people living with HIV.

Read More →

New project will dramatically increase pediatric TB prevention, diagnosis, and treatment in Zimbabwe

Harare, 31 May 2018 – The Zimbabwe government in partnership with Unitaid and the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) today launched a four-year project to fight tuberculosis among children, a long-underserved group that bears the burden of TB illness and death worldwide. TB, a preventable, curable disease, is the second biggest killer of children in Zimbabwe. 

Read More →

Unitaid seeks to fund innovative projects against TB and drug-resistance

Unitaid launched a call for proposals for projects that will fight tuberculosis and its drug-resistant strains through innovative diagnostics, wider use of the best new drugs for adults and children, and new technologies that remind patients to take their medicines on schedule.

Read More →

Page 1 of 3 · Total posts: 10

1 2 Last→